Mode
Text Size
Log in / Sign up
N/A N=35 Randomized Treatment

Diabetes Prevention Program Feasibility Study of Breastfeeding

Pregnancy · Overweight and Obesity

Enrolled (actual)
35
Serious AEs
5.7%
Results posted
Jan 2025
Primary outcome: Primary: Change in Weight — 7.5; 13.4; 18.2; -5.6 kgs

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Diabetes Prevention Program (Behavioral); Breastfeeding Education (Behavioral); Usual Care (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
Female
Sponsor
University of Kansas Medical Center
Primary completion
May 2021

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Weight
7.5; 13.4; 18.2; -5.6; -12.3; -11.2
PRIMARY
Change in HbA1c
5.2; 5.2; 5.0; 5.3; 5.4; 5.1
PRIMARY
Change in Arterial Blood Pressure
85.0; 90.7; 89.7; 92.7; 91.3; 90.8
PRIMARY
Duration of Breastfeeding
4; 7; 6; 1; 4; 4
SECONDARY
Breastfeeding Self-Efficacy Scale-Short Form (BSES-SF, Survey)
33.0; 35.0; 41.0; 49.0; 52.0; 62.5
SECONDARY
Kaiser Physical Activity Survey (KPAS, Weighted Total)
12.1; 10.1; 10.6; 12.4; 12.2; 10.6
SECONDARY
Fruit & Vegetable Intake Screener (EATS)
1.6; 1.8; 1.9; 1.9; 1.8; 3.1
SECONDARY
Edinburgh Postnatal Depression Scale (EPDS)
7; 6; 5; 7.5; 6; 4

Summary

The purpose of this study is to learn about the impact of the Diabetes Prevention Program (DPP) coupled with intensive breastfeeding support to help overweight or obese pregnant women lose weight postpartum, improve their blood sugars and blood pressure, and increase duration of breastfeeding their infant.

Eligibility Criteria

Inclusion Criteria

  • Pregnant, 1st trimester or early 2nd trimester
  • Interested in breastfeeding
  • BMI >/= 25 and /= 35
  • Unable to attend intervention / follow-up visits
  • Unwilling to self-monitor data collection
  • Unable to complete intervention
  • Presence of any condition that limits walking
  • Presence of any condition that limits following diet recommendations
  • Pregnancies complicated with fetuses diagnosed with lethal malformations / conditions
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04021602). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search